Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07844070
A Study of Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy
Sponsor: Novartis Pharmaceuticals
View on ClinicalTrials.gov
Summary
This study aims to assess the real-world patterns of disease modifying therapy (DMT) use before, during, and after pregnancy in women with multiple sclerosis (MS). The study will use a pooled closed claims database containing closed payer medical and pharmacy claims data for patients in the United States (US).
Official title: Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy
Key Details
Gender
FEMALE
Age Range
18 Years - 49 Years
Study Type
OBSERVATIONAL
Enrollment
2607
Start Date
2026-03-06
Completion Date
2026-10-30
Last Updated
2026-09-28
Healthy Volunteers
No
Conditions
Locations (1)
Novartis
East Hanover, New Jersey, United States